Cargando…
Three optimized assays for the evaluation of compounds that can rescue p53 mutants
Identifying drugs targeting p53 remains a major focus of precision oncology, with over twenty compounds that can rescue p53 mutants reported. Here, we suggest three easily accessible assays to determine the thermostability, protein folding, and transcriptional activity of p53 mutants—the go-to crite...
Autores principales: | Wu, Jiale, Song, Huaxin, Wang, Zhengyuan, Lu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339244/ https://www.ncbi.nlm.nih.gov/pubmed/34382015 http://dx.doi.org/10.1016/j.xpro.2021.100688 |
Ejemplares similares
-
Broad-spectrum rescue compounds for structural p53 mutations: perspective on ‘Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site’
por: Wu, Jia-Le, et al.
Publicado: (2021) -
Halogen-Enriched Fragment
Libraries as Leads for Drug
Rescue of Mutant p53
por: Wilcken, Rainer, et al.
Publicado: (2012) -
Ensemble-Based Computational Approach Discriminates Functional Activity of p53 Cancer and Rescue Mutants
por: Demir, Özlem, et al.
Publicado: (2011) -
Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells
por: Wu, Jiale, et al.
Publicado: (2021) -
Optimized in vitro three-dimensional invasion assay for quantifying a wide range of cancer cell invasive behavior
por: Hill, Samantha M., et al.
Publicado: (2022)